PortfoliosLab logoPortfoliosLab logo
BTEC.L vs. BTEK.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BTEC.L vs. BTEK.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L) and iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

BTEC.L is traded in USD, while BTEK.L is traded in GBP. To make them comparable, the BTEK.L values have been converted to USD using the latest available exchange rates.

Returns By Period

The year-to-date returns for both stocks are quite close, with BTEC.L having a 15.22% return and BTEK.L slightly lower at 15.09%.


BTEC.L

1D
0.68%
1M
9.55%
6M
13.18%
YTD
15.22%
1Y
50.31%
3Y*
16.99%
5Y*
5.87%
10Y*

BTEK.L

1D
1.00%
1M
9.60%
6M
13.21%
YTD
15.09%
1Y
50.03%
3Y*
17.58%
5Y*
5.91%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

BTEC.L vs. BTEK.L - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BTEC.L
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
15.22%32.96%-2.04%6.22%-11.92%-0.49%27.40%25.57%-11.22%-3.31%
BTEK.L
iShares Nasdaq US Biotechnology UCITS ETF
15.09%32.98%-1.86%5.59%-12.08%-0.02%26.89%26.51%-11.14%-26.81%

Correlation

The correlation between BTEC.L and BTEK.L is 0.97 - these two move nearly in lockstep. At this level, holding both provides almost no diversification benefit. If you already own one, adding the other does little to reduce portfolio risk.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.97

Correlation (3Y)
Calculated over the trailing 3-year period

0.95

Correlation (5Y)
Calculated over the trailing 5-year period

0.95

Correlation (All Time)
Calculated using the full available price history since Oct 19, 2017

0.93

The correlation between BTEC.L and BTEK.L has been stable across timeframes, ranging from 0.93 to 0.97 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BTEC.L vs. BTEK.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BTEC.L
BTEC.L Risk / Return Rank: 9090
Overall Rank
BTEC.L Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
BTEC.L Sortino Ratio Rank: 8989
Sortino Ratio Rank
BTEC.L Omega Ratio Rank: 8282
Omega Ratio Rank
BTEC.L Calmar Ratio Rank: 9595
Calmar Ratio Rank
BTEC.L Martin Ratio Rank: 9393
Martin Ratio Rank

BTEK.L
BTEK.L Risk / Return Rank: 9191
Overall Rank
BTEK.L Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
BTEK.L Sortino Ratio Rank: 8989
Sortino Ratio Rank
BTEK.L Omega Ratio Rank: 8484
Omega Ratio Rank
BTEK.L Calmar Ratio Rank: 9696
Calmar Ratio Rank
BTEK.L Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BTEC.L vs. BTEK.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L) and iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BTEC.LBTEK.LDifference
Sharpe ratioReturn per unit of total volatility

-0.06

Sortino ratioReturn per unit of downside risk

-0.06

Omega ratioGain probability vs. loss probability

1.39

1.40

-0.01

Calmar ratioReturn relative to maximum drawdown

6.22

6.38

-0.16

Martin ratioReturn relative to average drawdown

19.15

18.62

+0.52

BTEC.L vs. BTEK.L - Sharpe Ratio Comparison

The current BTEC.L Sharpe Ratio is 2.42, which is comparable to the BTEK.L Sharpe Ratio of 2.48. The chart below compares the historical Sharpe Ratios of BTEC.L and BTEK.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BTEC.L vs. BTEK.L - Drawdown Comparison

The maximum BTEC.L drawdown since its inception was -38.42%, roughly equal to the maximum BTEK.L drawdown of -38.25%. Use the drawdown chart below to compare losses from any high point for BTEC.L and BTEK.L.


Loading charts...

Drawdown Indicators


BTEC.LBTEK.LDifference

Max Drawdown

Largest peak-to-trough decline

-38.42%

-38.25%

-0.17%

Max Drawdown (1Y)

Largest decline over 1 year

-7.94%

-7.81%

-0.13%

Max Drawdown (3Y)

Largest decline over 3 years

-26.74%

-26.89%

+0.15%

Max Drawdown (5Y)

Largest decline over 5 years

-38.42%

-38.25%

-0.17%

Current Drawdown

Current decline from peak

-3.87%

-4.00%

+0.13%

Average Drawdown

Average peak-to-trough decline

-13.22%

-18.08%

+4.86%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.58%

2.68%

-0.10%

Volatility

BTEC.L vs. BTEK.L - Volatility Comparison

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L) and iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) have volatilities of 5.91% and 5.94%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BTEC.LBTEK.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.91%

5.94%

-0.03%

Volatility (6M)

Calculated over the trailing 6-month period

15.67%

15.62%

+0.05%

Volatility (1Y)

Calculated over the trailing 1-year period

20.42%

20.15%

+0.27%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.39%

24.78%

-3.39%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.37%

25.60%

-3.23%

BTEC.L vs. BTEK.L - Expense Ratio Comparison

Both BTEC.L and BTEK.L have an expense ratio of 0.35%.


Dividends

BTEC.L vs. BTEK.L - Dividend Comparison

Neither BTEC.L nor BTEK.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


With a correlation of 0.97, BTEC.L and BTEK.L move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.

Both ETFs have the same 0.35% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.

BTEC.L and BTEK.L have the same expense ratio: 0.35% per year.

BTEC.L tracks NASDAQ Biotechnology NET Index, while BTEK.L tracks NASDAQ Biotechnology TR USD.

Portfolio Optimizer

Find the right allocation for BTEC.L and BTEK.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer